We are proud to announce our partnership with the Atrial Fibrillation Institute and Queensland Cardiovascular Group aimed a improving health outcomes for patients with Atrial Fibrillation.
A heart condition which affects approximately 500,000 Australians, Atrial Fibrillation (AF) causes an irregular and often abnormally fast heart rate. AF greatly increases the risk of stroke, so early diagnosis and treatment is crucial in changing health outcomes.
The partnership aims to deliver a technology based solution for this complex heart condition which will provide a much needed care pathway for patients while also supporting the clinicians and physicians treating them.
We look forward to working with the innovative team at the Atrial Fibrillation Institute to build solutions that address the needs of those living with AF.